Other

Depomed rejects Horizon's latest takeover offer

Depomed Inc. on Monday rejected Horizon Pharma PLC's sweetened $2.4 billion hostile takeover offer, saying it still undervalues the company, and recommended that its shareholders reject the bid.

Sep 14, 2015
popularity7 comments 0